Status:
RECRUITING
Long-Term Follow-Up of Recipient of Gene Transfer Research
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Center for Research Resources (NCRR)
National Cancer Institute (NCI)
Conditions:
Retroviridae Infections
Cancer
Eligibility:
All Genders
Brief Summary
The goal of this clinical research study is to collect information about the long-term safety of gene transfer therapy. This study is also designed to create a database of medical information about pa...
Detailed Description
Study Procedures for Years 1-5: If you agree to take part in this study, you will come to the clinic for study visits once a year during Years 1-5. It is your choice whether to visit your regular loc...
Eligibility Criteria
Inclusion
- Patient or patient's legal representative(s) provided written informed consent to participate in a gene transfer study at the University of Texas MD Anderson Cancer Center (MD Anderson).
- Patient will receive vector or vector-treated cells at MD Anderson.
- Patient or patient's legal representative(s) is/are able to provide written informed consent to participate in this long-term follow-up protocol for gene transfer participants for up to 15 years following administration of gene therapy product.
- Agree to allow clinical samples to be collected and stored at MD Anderson and/or at a NIH designated facility such as the NGVB.
Exclusion
- 1\) Subject's gene transfer protocol is not approved at MD Anderson Cancer Center.
Key Trial Info
Start Date :
December 9 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT01492036
Start Date
December 9 2011
End Date
December 31 2027
Last Update
January 7 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030